Novel therapeutic interventions towards improved management of septic arthritis
Open Access
- 9 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 22 (1), 1-18
- https://doi.org/10.1186/s12891-021-04383-6
Abstract
Septic arthritis (SA) represents a medical emergency that needs immediate diagnosis and urgent treatment. Despite aggressive treatment and rapid diagnosis of the causative agent, the mortality and lifelong disability, associated with septic arthritis remain high as close to 11%. Moreover, with the rise in drug resistance, the rates of failure of conventional antibiotic therapy have also increased. Among the etiological agents frequently isolated from cases of septic arthritis, Staphylococcus aureus emerges as a dominating pathogen, and to worsen, the rise in methicillin-resistant S. aureus (MRSA) isolates in bone and joint infections is worrisome. MRSA associated cases of septic arthritis exhibit higher mortality, longer hospital stay, and higher treatment failure with poorer clinical outcomes as compared to cases caused by the sensitive strain i.e methicillin-sensitive S. aureus (MSSA).In addition to this, equal or even greater damage is imposed by the exacerbated immune response mounted by the patient’s body in a futile attempt to eradicate the bacteria. The antibiotic therapy may not be sufficient enough to control the progression of damage to the joint involved thus, adding to higher mortality and disability rates despite the prompt and timely start of treatment. This situation implies that efforts and focus towards studying/understanding new strategies for improved management of sepsis arthritis is prudent and worth exploring.The review article aims to give a complete insight into the new therapeutic approaches studied by workers lately in this field. To the best of our knowledge studies highlighting the novel therapeutic strategies against septic arthritis are limited in the literature, although articles on pathogenic mechanism and choice of antibiotics for therapy, current treatment algorithms followed have been discussed by workers in the past. The present study presents and discusses the new alternative approaches, their mechanism of action, proof of concept, and work done so far towards their clinical success. This will surely help to enlighten the researchers with comprehensive knowledge of the new interventions that can be used as an adjunct therapy along with conventional treatment protocol for improved success rates.This publication has 187 references indexed in Scilit:
- Differential arthritogenicity of Staphylococcus aureusstrains isolated from biological samplesBMC Infectious Diseases, 2013
- Serum Procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitisJournal of Orthopaedic Surgery and Research, 2013
- Orthopaedic biofilm infectionsCurrent Orthopaedic Practice, 2011
- Evidence-based Diagnostics: Adult Septic ArthritisAcademic Emergency Medicine, 2011
- Panton–Valentine Leukocidin Enhances the Severity of Community-Associated Methicillin-Resistant Staphylococcus aureus Rabbit OsteomyelitisPLOS ONE, 2009
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8The Journal of Experimental Medicine, 2009
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defenseTrends in Immunology, 2009
- Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055World Journal of Microbiology and Biotechnology, 2009
- Septic arthritis in patients with rheumatoid arthritisJournal of Orthopaedic Surgery and Research, 2008
- Efficacy of Bacteriophage Therapy against Gut-Derived Sepsis Caused by Pseudomonas aeruginosa in MiceAntimicrobial Agents and Chemotherapy, 2007